The aims of this research are to investigate further the uses of technetium complexes containing substituted isonitrile ligands in routine clinical nuclear medicine. The objective is to capitalize upon technology originally developed in these laboratories that has since led to the clinical trials of a new myocardial perfusion agent (99mTc-MIBI) now underway in U.S. and European medical centers. The isonitrile class of compounds in principle constitute a very large number of different chemical species with widely differing biological distribution properties. This is possible because the ligands (CN-R) are carbon-bonded to the central metal atom, thus allowing the nature of the inner coordination sphere of the complexes to be modified by varying the substituent R group. To investigate the full potential of this class requires a combination of chemical, biochemical and biological studies at both macroscopic and tracer concentrations using the long-lived radionuclide Tc-99 and the short-lived gamma emitter Tc-99m. This proposal describes, therefore, a program to synthesize and characterize technetium complexes containing a variety of substituted isonitrile ligands and to evaluate their potential as new radiopharmaceuticals. The procedures will include complete chemical identification of the compounds at carrier added levels and transfer of the chemistry to no carrier added concentrations for biological evaluation. This portion of the research will involve developing new methods of synthesis and analysis, so that structure-activity relationships can be examined by in vivo and in vitro studies using well-defined chemical species. The mechanisms of action of those members of the class that have already been shown to be effective for imaging the human heart will be examined. In addition, other applications of this versatile series of complexes will be investigated, for example, cardiac agents that reflect processes other than simple perfusion and radiopharmaceuticals for studying lung, hepatobiliary, and renal function.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA034970-11
Application #
3172756
Study Section
Diagnostic Radiology Study Section (RNM)
Project Start
1977-02-01
Project End
1991-12-31
Budget Start
1989-02-21
Budget End
1989-12-31
Support Year
11
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
Schools of Medicine
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Zaheer, A; Lenkinski, R E; Mahmood, A et al. (2001) In vivo near-infrared fluorescence imaging of osteoblastic activity. Nat Biotechnol 19:1148-54
Packard, A B; Barbarics, E; Kronauge, J F et al. (1997) Comparison of uptake of 99mTc-alkylisonitriles in the rat 9L gliosarcoma tumor model. Nucl Med Biol 24:21-5
Herman, L W; Sharma, V; Kronauge, J F et al. (1995) Novel hexakis(areneisonitrile)technetium(I) complexes as radioligands targeted to the multidrug resistance P-glycoprotein. J Med Chem 38:2955-63
Verdera, S; Lopez, J J; Tagle, R et al. (1994) Radiopharmacological evaluation in dogs of a new renal function agent. J Nucl Biol Med 38:79-85
Piwnica-Worms, D P; Kronauge, J F; LeFurgey, A et al. (1994) Mitochondrial localization and characterization of 99Tc-SESTAMIBI in heart cells by electron probe X-ray microanalysis and 99Tc-NMR spectroscopy. Magn Reson Imaging 12:641-52
Barbarics, E; Kronauge, J F; Costello, C E et al. (1994) In vivo metabolism of the technetium isonitrile complex [Tc(2-ethoxy-2-methyl-1-isocyanopropane)6]+. Nucl Med Biol 21:583-91
Packard, A B; Kronauge, J F; Limpa-Amara, N et al. (1993) Tumor uptake of 99mTc-MIBI and 201Tl by a 9L gliosarcoma brain tumor model in rats. Nucl Med Biol 20:773-6
Verdera, S; Leon, A; Kronauge, J F et al. (1993) Radiopharmacological studies of 99mTc-CPI: experience with isolated rat atrial tissue. Nucl Med Biol 20:127-32
Carvalho, P A; Chiu, M L; Kronauge, J F et al. (1992) Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. J Nucl Med 33:1516-22
Delmon-Moingeon, L I; Mahmood, A; Davison, A et al. (1991) Strategies for labeling monoclonal antibodies and antibody-like molecules with technetium-99m. J Nucl Biol Med 35:47-59

Showing the most recent 10 out of 16 publications